Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

for
Colorectal Cancer, CRC, Pancreatic Ductal Adenocarcinoma, PDAC,
Location: Fairfax VA, Baltimore MD, Philadelphia PA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06445062

Phase1, Phase2, Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

for
Neurofibromatosis Type 2, Vestibular Schwannoma,
Location: Baltimore MD, New York NY, Boston MA, Miami FL,
Sponsor: Scott R. Plotkin, MD, PhD

Sex: All

Age: 12+

Code: NCT04374305

Phase2, Recruiting

A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

for
COVID-19
Location: Baltimore MD, Boston MA, Decatur GA, St Louis MO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 64

Code: NCT07536308

Phase1, Recruiting

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

for
Multiple Myeloma
Location: Fairfax VA, Columbia MD, Newark DE, Elizabeth City NC,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05972135

Phase2, Recruiting

Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

for
Multiple Sclerosis
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 65

Code: NCT07389590

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

for
Small Cell Lung Cancer (SCLC),
Location: Fairfax VA, Baltimore MD, Durham NC, Chapel Hill NC,
Sponsor: Phanes Therapeutics

Sex: All

Age: 18+

Code: NCT05652686

Phase1, Phase2, Recruiting

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

for
Dementia, Potentially Inappropriate Medication Use,
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 65+

Code: NCT07454824

Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Fairfax VA, Columbia MD, Philadelphia PA,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase1, Phase2, Recruiting

Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine

for
Migraine, Chronic Migraine Headache, Refractory Migraine
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT07223008

Recruiting

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

for
Negative Symptoms of Schizophrenia
Location: Gaithersburg MD, Marlton NJ, New York NY, Decatur GA,
Sponsor: Minerva Neurosciences

Sex: All

Age: 18 - 55

Code: NCT07565428

Phase3, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Fairfax VA, Baltimore MD, Hershey PA, Morristown NJ,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase3, Recruiting

Evaluating Buspirone to Treat Opioid Withdrawal

for
Opioid Use Disorder, Opioid Withdrawal, Opioid Craving, Anxiety
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18 - 70+

Code: NCT05511909

Phase2, Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Fairfax VA, Baltimore MD, New York NY, Durham NC,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase1, Recruiting

Pregnenolone as a Treatment for Cannabis Intoxication

for
Cannabis Intoxication
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 65

Code: NCT07216690

Phase2, Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: Fairfax VA, Baltimore MD, New York NY, Durham NC,
Sponsor: Pathos AI, Inc.

Sex: Male

Age: 18+

Code: NCT06785636

Phase1, Phase2, Recruiting

Evaluation of the Diagnostic and Therapeutic Value of Tissue Ultrafiltration in Patients at Risk of Acute Compartment Syndrome (ACS)

for
Acute Compartment Syndrome, Fracture, Bone, Tibial Fractures
Location: Baltimore MD, Charlotte NC, Nashville TN,
Sponsor: Major Extremity Trauma Research Consortium

Sex: All

Age: 18 - 60

Code: NCT05889559

Recruiting

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Fairfax VA, Baltimore MD, New York NY, Norwalk CT,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase1, Recruiting

Effectiveness of the WearME System for COPD Severity and Respiratory Function

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Baltimore MD, Salisbury MD
Sponsor: LASARRUS Clinic and Research Center

Sex: All

Age: 21 - 70+

Code: NCT06751537

Recruiting

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

for
Glaucoma
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT06993597

Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: Fairfax VA, Columbia MD, Wynnewood PA, New York NY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase2, Recruiting